| Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701) (NCT01381666) | Merck Sharp & Dohme LLC | 2003-01-01 |
| A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008) (NCT00418366) | Merck Sharp & Dohme LLC | 2003-01-01 |
| MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) (NCT00076869) | Merck Sharp & Dohme LLC | 2003-01-01 |
| Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025) (NCT00543751) | Merck Sharp & Dohme LLC | 2003-01-01 |
| A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED) (NCT00092846) | Merck Sharp & Dohme LLC | 2002-12-04 |
| Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) (NCT00092196) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) (NCT00482417) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED) (NCT00818272) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016) (NCT00092495) | Merck Sharp & Dohme LLC | 2002-12-01 |
| A Study in Subjects With Perennial Allergic Rhinitis (NCT00210015) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) (NCT00050336) | Merck Sharp & Dohme LLC | 2002-12-01 |
| A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0359-016) (NCT00482235) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Efficacy, Safety and Pharmacokinetics of Sugammadex (Org 25969; MK-8616) at 3 Different Time Points After 0.6 mg/kg Esmeron® in Male Participants (P05940; MK-8616-020). (NCT03519854) | Merck Sharp & Dohme LLC | 2002-12-01 |
| A Pharmacokinetic Evaluation Study in Healthy Volunteers (NCT00210054) | Merck Sharp & Dohme LLC | 2002-11-01 |
| GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026) (NCT00546624) | Merck Sharp & Dohme LLC | 2002-11-01 |
| MK0767 Glipizide Comparator Cardiac Safety Study (0767-018) (NCT00543010) | Merck Sharp & Dohme LLC | 2002-11-01 |
| An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071) (NCT00092183) | Merck Sharp & Dohme LLC | 2002-10-10 |
| Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED) (NCT00049842) | Merck Sharp & Dohme LLC | 2002-10-01 |
| Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) (NCT00092430) | Merck Sharp & Dohme LLC | 2002-09-26 |
| Treatment of Patients With Anxiety Disorder (0777-022) (NCT00539578) | Merck Sharp & Dohme LLC | 2002-09-01 |
| A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019) (NCT00703833) | Merck Sharp & Dohme LLC | 2002-09-01 |
| A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED) (NCT00533598) | Merck Sharp & Dohme LLC | 2002-09-01 |
| Dose Confirmation Efficacy Study (V260-007) (NCT00092443) | Merck Sharp & Dohme LLC | 2002-09-01 |
| A Study of MK0359 in Patients With Chronic Asthma (0359-013) (NCT00482898) | Merck Sharp & Dohme LLC | 2002-09-01 |
| A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) (NCT00140894) | Merck Sharp & Dohme LLC | 2002-08-06 |
| A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED) (NCT00092339) | Merck Sharp & Dohme LLC | 2002-08-01 |
| Remicade Safety Line (Study P03236)(COMPLETED) (NCT00748826) | Merck Sharp & Dohme LLC | 2002-08-01 |
| A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020) (NCT00543920) | Merck Sharp & Dohme LLC | 2002-08-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED) (NCT00048607) | Merck Sharp & Dohme LLC | 2002-07-30 |
| Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) (NCT00044486) | Merck Sharp & Dohme LLC | 2002-07-01 |
| Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED) (NCT00092482) | Merck Sharp & Dohme LLC | 2002-06-28 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073) (NCT00042029) | Merck Sharp & Dohme LLC | 2002-06-18 |
| Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) (NCT00092534) | Merck Sharp & Dohme LLC | 2002-06-14 |
| A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182) (NCT00092313) | Merck Sharp & Dohme LLC | 2002-06-01 |
| Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) (NCT00048724) | Merck Sharp & Dohme LLC | 2002-06-01 |
| A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183) (NCT00092326) | Merck Sharp & Dohme LLC | 2002-06-01 |
| A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED) (NCT00092300) | Merck Sharp & Dohme LLC | 2002-05-01 |
| PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) (NCT00039871) | Merck Sharp & Dohme LLC | 2002-05-01 |
| Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eye (NCT00037661) | Merck Sharp & Dohme LLC | 2002-04-01 |
| A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039) (NCT00090272) | Merck Sharp & Dohme LLC | 2002-04-01 |
| Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) (NCT00759109) | Merck Sharp & Dohme LLC | 2002-03-01 |
| Phase III PEG-Intron in HIV-infected Patients (Study P00738) (NCT00035360) | Merck Sharp & Dohme LLC | 2002-03-01 |
| An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) (NCT00092170) | Merck Sharp & Dohme LLC | 2002-03-01 |
| Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) (NCT00092469) | Merck Sharp & Dohme LLC | 2002-03-01 |
| Remicade® Crohn's Disease Registry Across Canada (Study P02793) (NCT00755937) | Merck Sharp & Dohme LLC | 2002-02-01 |
| Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED) (NCT00390260) | Merck Sharp & Dohme LLC | 2002-02-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063) (NCT00034944) | Merck Sharp & Dohme LLC | 2002-01-24 |
| Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED) (NCT00048594) | Merck Sharp & Dohme LLC | 2002-01-03 |
| Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED) (NCT00040131) | Merck Sharp & Dohme LLC | 2002-01-01 |
| Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) (NCT00451386) | Merck Sharp & Dohme LLC | 2002-01-01 |
| MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016) (NCT00703690) | Merck Sharp & Dohme LLC | 2002-01-01 |
| Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED) (NCT00517309) | Merck Sharp & Dohme LLC | 2001-12-28 |
| Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) (NCT00092521) | Merck Sharp & Dohme LLC | 2001-12-01 |
| A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802) (NCT00481702) | Merck Sharp & Dohme LLC | 2001-12-01 |
| Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) (NCT00092404) | Merck Sharp & Dohme LLC | 2001-12-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED) (NCT00035048) | Merck Sharp & Dohme LLC | 2001-11-21 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061) (NCT00035295) | Merck Sharp & Dohme LLC | 2001-11-08 |
| Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203) (NCT00434824) | Merck Sharp & Dohme LLC | 2001-11-01 |
| Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007) (NCT00109122) | Merck Sharp & Dohme LLC | 2001-11-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED) (NCT00034983) | Merck Sharp & Dohme LLC | 2001-10-29 |
| MK0767 in Type 2 Diabetes (0767-012) (NCT00543556) | Merck Sharp & Dohme LLC | 2001-10-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059) (NCT00035009) | Merck Sharp & Dohme LLC | 2001-09-20 |
| Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) (NCT00389987) | Merck Sharp & Dohme LLC | 2001-09-01 |
| Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED) (NCT00035282) | Merck Sharp & Dohme LLC | 2001-09-01 |
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) (NCT00034684) | Merck Sharp & Dohme LLC | 2001-07-01 |
| Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) (NCT00034697) | Merck Sharp & Dohme LLC | 2001-06-28 |
| A Study in Adult and Pediatric Patients With Cystic Fibrosis (NCT00034515) | Merck Sharp & Dohme LLC | 2001-06-01 |
| Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED) (NCT00040547) | Merck Sharp & Dohme LLC | 2001-06-01 |
| A Study in Subjects With Retinal Detachment (NCT00210067) | Merck Sharp & Dohme LLC | 2001-05-01 |
| A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003) (NCT00551915) | Merck Sharp & Dohme LLC | 2001-05-01 |
| A Study to Test the Safety and Effectiveness of an Investigational Vaccine in Infants (V419-002) (NCT00551629) | Merck Sharp & Dohme LLC | 2001-05-01 |
| Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) (NCT00034632) | Merck Sharp & Dohme LLC | 2001-04-01 |
| A Study to Diagnose Lung Cancer by Sputum Cytology (01-312) (NCT00210080) | Merck Sharp & Dohme LLC | 2001-04-01 |
| Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034) (NCT00229112) | Merck Sharp & Dohme LLC | 2001-04-01 |
| Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease (NCT00404131) | Merck Sharp & Dohme LLC | 2001-03-01 |
| Pediatric Expanded Access Program-Oral Solution (0831-908) (NCT00543530) | Merck Sharp & Dohme LLC | 2001-03-01 |
| Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease (NCT00403715) | Merck Sharp & Dohme LLC | 2001-02-01 |
| Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED) (NCT00040534) | Merck Sharp & Dohme LLC | 2001-01-01 |
| Rotavirus Efficacy and Safety Trial (REST)(V260-006) (NCT00090233) | Merck Sharp & Dohme LLC | 2001-01-01 |
| A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED) (NCT00541463) | Merck Sharp & Dohme LLC | 2001-01-01 |
| PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) (NCT00034671) | Merck Sharp & Dohme LLC | 2001-01-01 |
| Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) (NCT00533650) | Merck Sharp & Dohme LLC | 2000-12-01 |
| Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) (NCT00831545) | Merck Sharp & Dohme LLC | 2000-12-01 |
| Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7) (NCT00732641) | Merck Sharp & Dohme LLC | 2000-12-01 |
| A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) (NCT00985166) | Merck Sharp & Dohme LLC | 2000-08-01 |
| Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines (NCT00984295) | Merck Sharp & Dohme LLC | 2000-06-01 |
| Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED) (NCT00365716) | Merck Sharp & Dohme LLC | 2000-05-01 |
| Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) (NCT00985153) | Merck Sharp & Dohme LLC | 2000-03-01 |
| A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease (NCT00679718) | Merck Sharp & Dohme LLC | 2000-01-01 |
| A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122) (NCT00282386) | Merck Sharp & Dohme LLC | 1999-12-23 |
| A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution (NCT00680108) | Merck Sharp & Dohme LLC | 1999-09-01 |
| Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005) (NCT00365378) | Merck Sharp & Dohme LLC | 1999-09-01 |
| SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084) (NCT00002960) | Merck Sharp & Dohme LLC | 1999-06-01 |
| ProQuad Dose Selection Study (V221-011)(COMPLETED) (NCT00986232) | Merck Sharp & Dohme LLC | 1999-04-01 |
| Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer (NCT00003880) | Merck Sharp & Dohme LLC | 1999-02-01 |
| A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) (NCT00092391) | Merck Sharp & Dohme LLC | 1999-02-01 |
| Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease (NCT00034645) | Merck Sharp & Dohme LLC | 1999-01-01 |
| Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041) (NCT00034658) | Merck Sharp & Dohme LLC | 1998-12-01 |
| Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026) (NCT03547154) | Merck Sharp & Dohme LLC | 1998-10-22 |
| SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002) (NCT03552549) | Merck Sharp & Dohme LLC | 1998-08-05 |